Abbott to Pay $670 Million to Settle Baby-Formula Litigation
📍 How it ended
Abbott reached agreements to resolve a portion of litigation involving its specialty formulas for preterm infants, announcing a $670 million settlement to end about 2,000 infant formula claims. The company also settled an appeal over a prior $495 million verdict in the same market.
Epilogue added 40d ago, after coverage quieted.
Coverage (14)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Abbott to Pay $670 Million to Settle Baby-Formula Litigation WSJ · 67d ago broke it first
The story so far
- Velocity & Diffusion: Coverage escalated across 12 distinct news outlets with 14 published articles, achieving a live velocity of 12.
- Predictive Outlook: Newsylist algorithmic models forecast this story will remain a dominant headline through tomorrow.
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
"Abbott to Pay $670 Million to Settle Baby-Formula Litigation" developed substantial multi-source reporting across the Business sector, tracked across 12 distinct newsrooms by Newsylist.
Key reporting was led by TradingView, Law.com, ET HealthWorld and Drugwatch.com. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.
Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 40d ago.
The obvious questions
What drove coverage for Abbott to Pay $670 Million to Settle Baby-Formula Litigation?
Coverage spiked when 12 independent newsrooms published 14 verified reports during this coverage cycle.
How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.